123 related articles for article (PubMed ID: 8635575)
1. Use of immobilized synthetic peptides for the identification of contact sites between human interleukin-6 and its receptor.
Weiergräber O; Schneider-Mergener J; Grötzinger J; Wollmer A; Küster A; Exner M; Heinrich PC
FEBS Lett; 1996 Jan; 379(2):122-6. PubMed ID: 8635575
[TBL] [Abstract][Full Text] [Related]
2. The interleukin-6 (IL-6) partial antagonist (Q159E,T162P)IL-6 interacts with the IL-6 receptor and gp130 but fails to induce a stable hexameric receptor complex.
Hammacher A; Simpson RJ; Nice EC
J Biol Chem; 1996 Mar; 271(10):5464-73. PubMed ID: 8621403
[TBL] [Abstract][Full Text] [Related]
3. Global and local determinants for the kinetics of interleukin-4/interleukin-4 receptor alpha chain interaction. A biosensor study employing recombinant interleukin-4-binding protein.
Shen BJ; Hage T; Sebald W
Eur J Biochem; 1996 Aug; 240(1):252-61. PubMed ID: 8797861
[TBL] [Abstract][Full Text] [Related]
4. 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling.
Somers W; Stahl M; Seehra JS
EMBO J; 1997 Mar; 16(5):989-97. PubMed ID: 9118960
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction.
Kalai M; Montero-Julian FA; Grötzinger J; Fontaine V; Vandenbussche P; Deschuyteneer R; Wollmer A; Brailly H; Content J
Blood; 1997 Feb; 89(4):1319-33. PubMed ID: 9028955
[TBL] [Abstract][Full Text] [Related]
6. Identification of single amino acid residues of human IL-6 involved in receptor binding and signal initiation.
Ehlers M; Grötzinger J; Fischer M; Bos HK; Brakenhoff JP; Rose-John S
J Interferon Cytokine Res; 1996 Aug; 16(8):569-76. PubMed ID: 8877726
[TBL] [Abstract][Full Text] [Related]
7. Use of a biosensor with surface plasmon resonance detection for the determination of binding constants: measurement of interleukin-6 binding to the soluble interleukin-6 receptor.
Ward LD; Howlett GJ; Hammacher A; Weinstock J; Yasukawa K; Simpson RJ; Winzor DJ
Biochemistry; 1995 Mar; 34(9):2901-7. PubMed ID: 7893704
[TBL] [Abstract][Full Text] [Related]
8. The molecular design of human IL-6 receptor antagonists.
Lahm A; Savino R; Salvati AL; Cabibbo A; Ciapponi L; Demartis A; Toniatti C; Paonessa G; Altamura S; Ciliberto G
Ann N Y Acad Sci; 1995 Jul; 762():136-50; discussion 150-1. PubMed ID: 7668525
[No Abstract] [Full Text] [Related]
9. Characterization of a soluble IL-6 receptor alpha mutant C277D/H280I expressed in E.coli.
Duan J; Wang J; Cai X; Wang L; Liu H; Zou M
Biochem Mol Biol Int; 1997 May; 41(6):1101-8. PubMed ID: 9161704
[TBL] [Abstract][Full Text] [Related]
10. Identification of the domain in the human interleukin-11 receptor that mediates ligand binding.
Schleinkofer K; Dingley A; Tacken I; Federwisch M; Müller-Newen G; Heinrich PC; Vusio P; Jacques Y; Grötzinger J
J Mol Biol; 2001 Feb; 306(2):263-74. PubMed ID: 11237599
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6: structure-function relationships.
Simpson RJ; Hammacher A; Smith DK; Matthews JM; Ward LD
Protein Sci; 1997 May; 6(5):929-55. PubMed ID: 9144766
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of recombinant human interleukin-6.
Xu GY; Yu HA; Hong J; Stahl M; McDonagh T; Kay LE; Cumming DA
J Mol Biol; 1997 May; 268(2):468-81. PubMed ID: 9159484
[TBL] [Abstract][Full Text] [Related]
13. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
14. Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes.
Jerva LF; Sullivan G; Lolis E
Protein Sci; 1997 Aug; 6(8):1643-52. PubMed ID: 9260277
[TBL] [Abstract][Full Text] [Related]
15. The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes.
Grötzinger J; Kurapkat G; Wollmer A; Kalai M; Rose-John S
Proteins; 1997 Jan; 27(1):96-109. PubMed ID: 9037715
[TBL] [Abstract][Full Text] [Related]
16. Monomeric and dimeric forms of soluble receptors can differ in their neutralization potential.
Lauffer L; Kanzy EJ; Köhler R; Kurrle R; Enssle K; Seiler FR
Behring Inst Mitt; 1995 Jun; (96):21-31. PubMed ID: 7575349
[TBL] [Abstract][Full Text] [Related]
17. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
Skiniotis G; Boulanger MJ; Garcia KC; Walz T
Nat Struct Mol Biol; 2005 Jun; 12(6):545-51. PubMed ID: 15895091
[TBL] [Abstract][Full Text] [Related]
18. Identification of a soluble, high affinity human interleukin 4 binding protein in normal human urine.
Christie G; Dacey I; Weston BJ
Cytokine; 1995 May; 7(4):305-10. PubMed ID: 8589259
[TBL] [Abstract][Full Text] [Related]
19. Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells.
Halimi H; Eisenstein M; Oh JW; Revel M; Chebath J
Eur Cytokine Netw; 1995; 6(3):135-43. PubMed ID: 8589270
[TBL] [Abstract][Full Text] [Related]
20. Molecular approaches to structure-function analysis of interleukin-8.
Fairbrother WJ; Lowman HB
Methods Enzymol; 1997; 287():45-58. PubMed ID: 9330314
[No Abstract] [Full Text] [Related]
[Next] [New Search]
